Article
Immunology
Stephane Carryn, Brigitte Cheuvart, Michael Povey, Alemnew F. Dagnew, Rafael Harpaz, Robbert van der Most, Giacomo Casabona
Summary: By analyzing immunogenicity data of adults, no consistent evidence of differences in varicella-zoster virus exposure was found between countries with widely circulating varicella and countries with universal vaccination, indicating the absence of reduced VZV exposure among older adults.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Immunology
Kazuhiro Matsumoto, Satoko Ohfuji, Kana Inohara, Masateru Akechi, Hiroko Kumashiro, Motoki Ishibashi, Shin Irie, Yoshio Hirota
Summary: The freeze-dried live attenuated varicella-zoster vaccine BIKEN is available in Japan for adults aged >= 50 years. A previous cohort study confirmed its safety, but evidence of vaccine effectiveness is limited.
Article
Obstetrics & Gynecology
Meenu Priyadarshini Nanthakumar, Akanksha Sood, Maimoona Ahmed, Janesh Gupta
Summary: Chickenpox during pregnancy can lead to serious complications, with prevention measures including vaccination and timely administration of varicella zoster immunoglobulin. Antiviral therapy and appropriate supportive treatment can improve maternal and neonatal outcomes.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
(2021)
Review
Virology
Yasmin Marra, Fawziah Lalji
Summary: Infection with varicella zoster virus can cause either chickenpox or shingles. Two vaccines are available to prevent shingles, with the recombinant vaccine showing higher efficacy than the live vaccine. Safety data from both vaccines indicate mostly local and mild systemic reactions.
Article
Microbiology
Tomohiko Sadaoka, Daniel P. Depledge, Labchan Rajbhandari, Judith Breuer, Arun Venkatesan, Jeffrey Cohen
Summary: The variant allele in the glycoprotein B (gB) gene plays a crucial role in the attenuation of the varicella vaccine. This variant impairs fusion, virus entry into neurons, and replication in human skin cells. Understanding the molecular basis for vaccine attenuation could aid in the development of other herpesvirus vaccines.
Review
Virology
Cristina Tommasi, Judith Breuer
Summary: The replication of varicella-zoster virus in the skin plays a critical role in its pathogenesis and spread. Understanding the virus's interaction with host signaling pathways and proteins associated with epidermal terminal differentiation is essential for studying viral replication and shedding, as well as developing vaccines.
Article
Clinical Neurology
Samir Abu-Rumeileh, Benjamin Mayer, Veronika Still, Hayrettin Tumani, Markus Otto, Makbule Senel
Summary: This study retrospectively evaluated cases of VZV-ND following COVID-19 vaccination, finding that it may trigger neurological issues associated with VZV reactivation, but the benefits of vaccination significantly outweigh the potential risks.
JOURNAL OF NEUROLOGY
(2022)
Article
Immunology
Anne A. Gershon, Michael D. Gershon, Eugene D. Shapiro
Summary: The development and application of the varicella vaccine has brought significant health benefits to children and immunocompromised patients worldwide, reducing the incidence of varicella as well as decreasing the incidence of herpes zoster. Additionally, the vaccine provides protection against the varicella-zoster virus and offers an extra layer of prevention for susceptible adults.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Infectious Diseases
Marturod Buranasakda, Praew Kotruchin, Kittisap Phanthachai, Piroon Mootsikapun, Ploenchan Chetchotisakd
Summary: This study reports two cases of male patients who developed varicella zoster meningitis within 10 days after receiving COVID-19 vaccination. While most adverse effects are mild, possible serious adverse effects still need to be monitored cautiously.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Immunology
Zahra Bibi, Ahmed Daniyal Nawaz, Maha Al Kurbi, Shahad Fakhroo, Khaled Ferih, Noor Al-Jaber, Merin Alex, Khalid H. Elawad, Tawanda Chivese, Susu M. Zughaier
Summary: This study evaluated the real-world effectiveness of varicella vaccination in Qatar from 2017 to 2019. The results showed that two doses of varicella vaccination provided reasonable protection against varicella infection in the multicultural setting of Qatar.
Article
Dermatology
Kimiyasu Shiraki, Nozomu Toyama, Keiko Tanaka, Akiko Ito, Junko Yamamoto
Summary: The study showed that universal varicella vaccination can reduce the incidence of varicella and herpes zoster, but the trends of HZ incidence varied among different age groups after the disappearance of varicella epidemics and during the COVID-19 pandemic, which may be related to the frequency of varicella exposure.
JOURNAL OF DERMATOLOGICAL SCIENCE
(2021)
Article
Dermatology
Amin Amer, Amany Nassar, Doaa Gamal, Ayman Marei
Summary: The treatment of warts is a challenge, with immunotherapy showing promising results. Intralesional immunotherapy with Candida antigen and VZV vaccine has shown successful outcomes, with VZV vaccine being a promising and effective remedy for various types of warts, especially plantar warts.
DERMATOLOGIC THERAPY
(2021)
Article
Immunology
Han Cao, Yunfei Wang, Ning Luan, Kangyang Lin, Cunbao Liu
Summary: Comparing the humoral and cellular immunity induced by different gE mRNA vaccines, the study found that the C-terminal double mutant of gE showed stable advantages in all indicators tested, making it a candidate for both safer varicella vaccines and more effective zoster vaccines.
Article
Health Care Sciences & Services
Zhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, Chang-Gui Li, Xiao-Juan Yu, Ming-Qiang Li, Zhen Chen, Guo-Hua Zhong, De-Quan Pan, Li-Rong Huang, Bang-Jun Lv, Xue-Lian Cui, Qiao-Qiao Song, Ji-Zong Jia, Jin-Le Han, Wei Wang, Hua Zhu, Tong Cheng, Ying-Ying Su, Yi-Min Li, Xiang-Zhong Ye, Ting Wu, Jun Zhang, Ning-Shao Xia
Summary: This study evaluated the safety and immunogenicity of a skin and neuro-attenuated varicella vaccine candidate. The results showed that the vaccine candidate was well-tolerated and immunogenic in humans.
LANCET REGIONAL HEALTH-WESTERN PACIFIC
(2023)
Article
Biotechnology & Applied Microbiology
Ahmet Soysal, Erdem Gonullu, Ismail Yildiz, Metin Karabocuoglu
Summary: The study found a significant reduction in the incidence of Varicella in children aged <= 5 years in Turkey after the introduction of single dose Varicella vaccine, while there was a significant increment in the incidence of Herpes Zoster in adult population, particularly among adults aged 18-44 years.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)